SC
MRNA icon

Syon Capital’s Moderna MRNA Stock Holding History

Syon Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$265K Buy
+5,209
New +$243K 0.01% 781
2025
Q3 		– Sell
-9,918
Closed -$274K – 836
2025
Q2 		$274K Buy
+9,918
New +$261K 0.02% 580
2025
Q1 		– Sell
-11,134
Closed -$463K – 633
2024
Q4 		$463K Buy
+11,134
New +$532K 0.04% 302
2024
Q3 		– Sell
-2,595
Closed -$308K – 480
2024
Q2 		$308K Buy
2,595
+709
+38% +$89.7K 0.03% 345
2024
Q1 		$201K Buy
+1,886
New +$190K 0.02% 430

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Syon Capital's MRNA Position: Q1 2026 in Review

Syon Capital opened a new position in Moderna (MRNA) in Q1 2026: 5,209 shares worth $265K. The stake represents 0.01% of the portfolio and ranks #781 among its holdings. This is a return to the name: Syon Capital previously reported a position in MRNA as recently as Q2 2025.

Syon Capital first reported a position in MRNA in Q1 2024 and has held it in 5 quarters since. The position peaked at $463K in Q4 2024. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Syon Capital held 5,209 shares of Moderna worth $265K as of Q1 2026.
  • Moderna was a new Syon Capital position in Q1 2026.
  • Moderna made up 0.01% of Syon Capital's portfolio in Q1 2026, its #781 holding.
  • Syon Capital first reported a position in Moderna in Q1 2024 and has held it in 5 quarters since.
  • Syon Capital's Moderna position peaked at $463K in Q4 2024.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.